The results of xelox (capecitabine plus oxaliplatin) in metastatic colorectal cancer: A single center experience

被引：0
|
作者：
Yaman, Emel [1 ]
Yildiz, Ramazan [1 ]
Kaya, A. Osman [1 ]
Ozturk, Banu [1 ]
Buyukberber, Suleyman [1 ]
Coskun, Ugur [1 ]
Benekli, Mustafa [1 ]
Yamac, Deniz [1 ]
Uner, Aytug [1 ]
机构：
[1] Gazi Med Fac, Ankara, Turkey
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [1] Two doses of oxaliplatin with capecitabine (XELOX) in metastatic colorectal cancer
    Moreno-Solorzano, Isabel
    Ibeas-Rollan, Rafael
    Monzo-Planella, Mariano
    Moreno-Solorzano, Jose
    Martinez-Rodenas, Francisco
    Pou-Sanchis, Edmon
    Hernandez-Borlan, Raquel
    Navarro-Vigo, Marta
    Ortigosa-Rodriguez, Silvia
    Gel-Moreno, Bernat
    CLINICAL COLORECTAL CANCER, 2007, 6 (09) : 634 - 640
  • [2] Capecitabine plus oxaliplatin in metastatic colorectal cancer
    Cassidy, Jim
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (31) : 5043 - 5045
  • [3] Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer
    Emel Yaman
    Aytug Uner
    Ozlem Er
    Ugur Coskun
    Suleyman Buyukberber
    Mustafa Dikilitas
    Mevlude Polat
    Deniz Yamac
    Ali Osman Kaya
    Ramazan Yildiz
    Banu Ozturk
    Mustafa Benekli
    Medical Oncology, 2007, 24 : 431 - 435
  • [4] Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer
    Yaman, Emel
    Uner, Aytug
    Er, Ozlem
    Coskun, Ugur
    Buyukberber, Suleyman
    Dikilitas, Mustafa
    Polat, Mevlude
    Yamac, Deniz
    Kaya, Ali Osman
    Yildiz, Ramazan
    Ozturk, Barm
    Benekli, Mustafa
    MEDICAL ONCOLOGY, 2007, 24 (04) : 431 - 435
  • [5] Capecitabine plus oxaliplatin in metastatic colorectal cancer - In reply
    Porschen, Rainer
    Arkenau, Hendrik-Tobias
    Kubicka, Stefan
    Greil, Richard
    Seufferlein, Thomas
    Freier, Werner
    Kretzschmar, Albrecht
    Graeven, Ullrich
    Grothey, Axel
    Hinke, Axel
    Schmiegel, Wolff
    Schmoll, Hans-Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (31) : 5045 - 5046
  • [6] XELOX (capecitabine plus oxaliplatin):: Active first-line therapy for patients with metastatic colorectal cancer
    Cassidy, J
    Tabernero, J
    Twelves, C
    Brunet, R
    Butts, C
    Conroy, T
    Debraud, F
    Figer, A
    Grossmann, J
    Sawada, N
    Schöffski, P
    Sobrero, A
    Van Cutsem, E
    Diaz-Rubio, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2084 - 2091
  • [7] Capecitabine and oxaliplatin (XELOX) in combination with bevacizumab in the treatment of metastatic colorectal cancer: results of a phase II trial
    Bendell, J.
    Yu, D.
    Hurwitz, H.
    Morse, M.
    Blobe, G.
    Gockerman, J.
    Odogwu, L.
    Mahon, M.
    Truax, R.
    Fernando, N.
    EJC SUPPLEMENTS, 2005, 3 (02): : 189 - 189
  • [8] Capecitabine and oxaliplatin (XELOX) as first line treatment for patients with metastatic colorectal cancer (MCRC)
    Karacetin, D.
    Maral, O.
    Yalcyn, B.
    Okten, B.
    Incekara, O.
    ANNALS OF ONCOLOGY, 2006, 17 : 73 - 73
  • [9] Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer
    Karacetin, D.
    Yalcin, B.
    Okten, B.
    Ozturk, S.
    Maral, O.
    Incekara, O.
    JOURNAL OF BUON, 2009, 14 (04): : 605 - 608
  • [10] A phase II study of capecitabine plus oxaliplatin (XELOX)A new first-line option in metastatic colorectal cancer
    Thomas Makatsoris
    Haralabos P. Kalofonos
    Gerasimos Aravantinos
    Christos Papadimitriou
    Efstathios Kastritis
    Sotirios K. Rigatos
    Nikolaos Xiros
    Theodore Petsas
    Theofanis Economopoulos
    Athanassios K. Sakadamis
    George Fountzilas
    International Journal of Gastrointestinal Cancer, 2005, 35 (2): : 103 - 109
12345